Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesis

British Journal of Cancer

Volumn 110, Issue 10, 2014, Pages 2593-2603

  Yan, J ^a,b   De Melo, J ^a,b   Cutz, J C ^a   Aziz, T ^a   Tang, D ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE 3A1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METASTASIS; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER CELL LINE; PROTEIN EXPRESSION; TUMOR XENOGRAFT; UPREGULATION;

ADENOCARCINOMA; ALDEHYDE DEHYDROGENASE; ANDROGENS; ANIMALS; BONE NEOPLASMS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; ENZYME INDUCTION; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED NOD; MICE, SCID; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; NEOPLASMS, HORMONE-DEPENDENT; NEOPLASTIC STEM CELLS; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS;

EID: 84900538153     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.201     Document Type: Article

References (79)

1. Bonnet D, Dick J (1997) Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 7: 730-737.
2. Brabletz T, Jung A, Spaderna S, Hlubek F, Kirchner T (2005) Opinion: Migrating cancer stem cells-an integrated concept of malignant tumour progression. Nat Rev Cancer 5(9) : 744-749.
3. Burger P, Gupta R, Xiong X, Ontiveros C, Salm S, Moscatelli D, Wilson E (2009) High aldehyde dehydrogenase activity: A novel functional marker of murine prostate stem/progenitor cells. Stem Cell 27: 2220-2228.
4. Canuto R, Muzio G, Ferro M, Maggiora M, Federa R, Bass A, Lindahl R, Dianzani M (1999) Inhibition of class 3 aldehyde dehydrogenase and cell growth by restored lipid peroxidation in heptoma cell lines. Fre e Radic Biol Med 26: 333-340.
5. Charafe-Jauffret E, Ginestier C, Iovino F, Tarpin C, Diebel M, Esterni B, Houvenaeghel G, Extra J-M, Bertucci F, Jacquemier J, Xerri L, Dontu G, Stass i G, Xiao Y, Barsky SH, Birnbaum D, Viens P, Wicha MS (2010) Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin Cancer Res 16: 45-5 5.
6. Chen Y, Koppaka V, Thompson DC, Vasiliou V (2012) ALDH1A1: From lens and corneal crystallin to stem cell marker. Exp Eye Res 102: 105-106.
7. Chen Y, Orlicky DJ, Matsumoto A, Sing h S, Thompson DC, Vasiliou V (2011) Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer. Biochem Biophys Res Commun 405: 173-179.
8. Choi N Zhang B Zhang L Ittmann M Xin L 2012 Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation Cancer Cell 21 2 253-265.
9. Collins AT, Berry PA, Hyde C, Stower MJ, Maitland NJ (2005) Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 65: 10946-10951.
10. Colombel M, Eaton CL, Hamdy F, Ricci E, Van Der Pluij m G, Cecchini M, Mege-Lechevallier F, Clezardin P, Thalmann G (2012) Increased expression of putative cancer stem cell markers in primary prostate cancer is associated with progression of bone metastases. Prostate 72(7) : 713-720.
11. Deng S, Yang X, Lassus H, Liang S, Kaur S, Ye Q, Li C, Wang L-P, Roby KF, Orsulic S, Connolly DC, Zhang Y, Montone K, Bützow R, Coukos G, Zhang L (2010) Dist inct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers. PLoS One 5: E10277.
12. Doherty RE, Haywood-Small SL, Sisley K, Cross NA (2011) Al dehyde dehydrogenase activity selects for the holoclone phenotype in prostate cancer cells. Biochem Biophys Res Commun 414: 801-807.
13. Douville J, Beaulieu R, Balicki D (2009) ALDH1 as a functional marker of cancer stem and progenitor cells. Stem Cells Dev 18: 17-25.
14. Fidler IJ, Hart IR (1982) Biological diversity in metastatic neoplasms: Origins and implications. Science 217: 998-1003.
15. Gasparetto M, Sekulovic S, Brocker C, Tang P, Zakaryan A, Xiang P, Kuchenbauer F, Wen M, Kasaian K, Witty MF, Rosten P, Chen Y, Imren S, Duester G, Thompson DC, Humphries RK, Vasiliou V, Smith C (2012) Aldehyde dehydrogenases are regulators of hematopoietic stem cell numbers and B-cell development. Exp Hematol 40(4): 318-329. e2.
16. Germann M, Wetterwald A, Guzmán-Ramirez N, Van Der P luijm G, Culig Z, Cecchini MG, Williams ED, Thalmann GN (2012) Stem-like cells with luminal progenitor phenotype survive castration in human prostate cancer. Stem Cells 30: 1076-1086.
17. Ginestier C, H ur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G (2007) ALDH1 is a marker of normal and maligna nt human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1(5): 555-567.
18. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON (2010) Identification of a cell of origin for human prostate cancer. Science 329: 568-571.
19. Greaves M (2013) Cancer stem cells as ?units of selection?. Evol Appl 6(1): 102-108.
20. Gu G, Yuan J, Wills M, Kasper S (2007) Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res 67: 4807-4815.
21. Gupta A, Christensen RG, Rayla AL, Lakshmanan A, Stormo GD, Wolfe SA (2012) An optimized two-finger archive for ZFN-mediated gene targeting. Nat Methods 9(6): 588-590.
22. Hayward SW, Dahiya R, Cunha GR, Bartek J, Deshpande N, Narayan SP (1995) Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1. In Vitro Cell Dev B iol 31A: 14-24.
23. Hellsten R, Johansson M, Dahlman A, Sterner O, Bjartell A (2011) Galiellalactone inhibits stem cell-like ALDH-positive prostate cancer cells. PLoS One 6(7): E22118.
24. Heppner GH, Miller BE (1983) Tumor heterogeneity: Biological implications and therapeutic consequences. Cancer Metastasis Rev 2(1): 5-23.
25. Huang EH, Hynes MJ, Zhang T, Ginestier C, Do ntu G, Appelman H, Fields JZ, Wicha MS, Boman BM (2009) Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res 69: 3382-3389.
26. Jiang F, Qiu Q, Khanna A, Todd NW, Deepak J, Xing L, Wang H, Liu Z, Su Y, Stass SA, Katz RL (2009) Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung can cer. Mol Cancer Res 7: 330-338.
27. Jones RJ, Barber JP, Vala MS, Collector MI, Kaufmann SH, Ludeman SM, Colvin OM, Hilton J (1995) Assessment of aldehyde dehydrogenase in viable cells. Blood 85: 2742-2746.
28. Kastan MB, Schlaffer E, Russo JE, Colvin OM, Civin CI, Hilton J (1990) Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells. Bloo d 75: 1947-1950.
29. Kelly K Yin JJ 2008 Prostate cancer and metastasis initiating stem cells Cell Res 18 528-537.
30. Kim H, Lapointe J, Kaygusuz G, Ong DE, Li C, v an De Rijn M, Brooks JD, Pollack JR (2005) The retinoic acid synthesis gene ALDH1a2 is a candidate tumor suppressor in prostate cancer. Cancer Res 65: 8118-8124.
31. Koppaka V, Thompson DC, Chen Y, Ellermann M, Nicolaou KC, Juvonen RO, Petersen D, Deitrich RA, Hurley TD, Vasiliou V (2012) Aldehyde dehydrogenase inhibitors: A comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinica l application. Pharmacol Rev 64: 520-539.
32. Landen Jr CN, Goodman B, Katre AA, Steg AD, Nick AM, Stone RL, Miller LD, Mejia PV, Jennings NB, Gershenson DM, Bast Jr RC, Coleman RL, Lopez-Berestein G, Sood AK (2010) Targeting aldehyde d ehydrogenase cancer stem cells in ovarian cancer. Mol Cancer Ther 9(12): 3186-3199.
33. Le Magnen C, Bubendorf L, Rentsch CA, Mengus C, Gsponer J, Zellweger T, Rieken M, Thalmann GN, Cecchin i MG, Germann M, Bachmann A, Wyler S, Heberer M, Spagnoli GC (2013) Characterization and clinical relevance of ALDHbright populations in prostate cancer. Clin Cancer Res 19(19): 5361-5371.
34. Leon g KG, Wang B-E, Johnson L, Gao W-Q (2008) Generation of a prostate from a single adult stem cell. Nature 456: 804-808.
35. Li H, Zhou J, Miki J, Furusato B, Gu Y, Srivastava S, McLeo d DG, Vogel JC, Rhim JS (2008) Telomerase-immortalized non-malignant human prostate epithelial cells retain the properties of multipotent stem cells. Exp Cell Res 314: 92-102.
36. Li T, Su Y, Mei Y, Leng Q, Leng B, Liu Z, Stass SA, Jiang F (2010) ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients?outcome. Lab Invest 90: 234-244.
37. Lingala S, Cui Y-Y, Chen X, Ruebner BH, Qian X-F, Zern MA, Wu J (2010) Immunohistochemical staining of cancer stem cell markers in hepatocellular carcinoma. Exp Mol Pathol 89: 27-35.
38. Ma I, Allan AL (2011) The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev 7(2): 292-306.
39. Mani SA, Yang J, Brooks M, Schwaninger G, Zhou A, Miura N, Kutok JL, Hartwell K, Richa rdson AL, Weinberg RA (2007) Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers. Proc Natl Acad Sci USA 104: 10069-10074.
40. Marcato P, Dea n C, Pan D, Araslanova R (2011) Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells 29: 32-45.
41. Marchitti S, Brocker C, Stagos D, Vasiliou V (2009) Non-P450 aldehyde oxidizing enzymes: The aldehyde dehydrogenase superfamily. Exp Opin Drug Metab Toxicol 4: 697-720.
42. Mehta R, Kyshtoobayeva A, Kurosaki T (2001) Independent association of angiogenesis index with outcome in prostate cancer. Clin Cancer Res 7: 81-88.
43. Miki J, Furusato B, Li H, Gu Y, Takahashi H, Egawa S, Sesterhenn IA, McLeo d DG, Srivastava S, Rhim JS (2007) Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens . Cancer Res 67: 3153-3161.
44. Moon C, Park JC, Chae YK, Yun JH, Kim S (2008) Current status of experimental therapeutics for prostate cancer. Cancer Lett 266: 116-134.
45. Moreb JS, Baker HV, Chang LJ, Amaya M, Lopez MC, Ostmark B, Chou W (2008) ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells. Mol Cancer 7: 87.
46. Moreb JS, Mohuczy D, Muhoczy D, Ostmark B, Zucali JR (2007) RNAimediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydrope roxycyclophosphamide. Cancer Chemother Pharmacol 59: 127-136.
47. Moreb JS, Ucar D, Han S, Amory JK, Goldstein AS, Ostmark B, Chang L-J (2012) The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance. Chem Biol Interact 195: 52-60.
48. Muzio G, Trombetta A, Maggiora M, Martinasso G, Vasiliou V, Lassen N, Canuto RA (2006) Arachidonic acid suppresses growth of human lung tumor A549 cells through down-regulation of ALDH3A1 expression. Free Radi c Biol Med 40: 1929-1938.
49. Muzio G, Trombetta A, Martinasso G, Canuto RA, Maggiora M (2003) Antisense oligonucleotides against aldehyde dehydrogenase 3 inhibit hepatoma cell proliferation by affecting MAP kinases. Chem Biol Interact 143-144: 37-43.
50. Nishida S Hirohashi Y Torigoe T Inoue R Kitamura H Tanaka T Takahashi A Asanuma H Masumori N Tsukamoto T Sato N 2013Prostate cancer stem-like cells/cancer-initiating cells have an autocrine system of hepatocyte growth factor Cancer Sci104 4 431-436.
51. Nishida S, Hirohashi Y, Torigoe T, Kitamura H, Takahashi A, Masumori N, Tsukamoto T, Sato N (2012) Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay. J Urol 188(1): 294-299.
52. Nowell PC (1986) Mechanisms of tumor progression mechanisms of tumor progression. Cancer Res 46: 2203-2207.
53. Pappa A, Brown D, Koutalos Y, DeGregori J, White C, Vasiliou V (2005) Human aldehyde dehydrogenase 3A1 inhibits proliferat ion and promotes survival of human corneal epithelial cells. J Biol Chem280(30): 27998-28006.
54. Patrawala L, Calhoun T, Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra D, Zhou J, Claypool K, Coghlan L, Tang DG (2006) Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 25: 1696-1708.
55. Qin J, Liu X, Laffin B, Chen X, Choy G, Jeter CR, Calhoun-Davis T, Li H, Palapattu GS, Pang S, Lin K, Huang J, Ivanov I, Li W, Suraneni MV, Tang DG (2012) The PSA(-/lo) prostate cancer cell pop ulation harbors self-renewing long-term tumor-propagating cells that resist castration. Cell stem cell 10: 556-569.
56. Randall LM, Monk BJ, Darcy KM, Tian C, Burger RA, Liao S-Y, Peters WA, Stock RJ, Fruehauf JP (2009) Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study. Gynecol Oncol 112: 583-589.
57. Reya T, Morrison SJ, Clarke MF, Weissman IL (2001) Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
58. Rosenberg J, Small EJ (2003) Prostate cancer update. Curr Opin Oncol 15: 217-221.
59. Ross JS (2007) The androgen receptor in prostate cancer: Therapy target in search of an integrated diagnostic test. Adv Anat Pathol 14: 353-357.
60. Rybak AP, He L, Kap oor A, Cutz JC, Tang D (2011) Characterization of sphere-propagating cells with stem-like properties from DU145 prostate cancer cells. Biochim Biophys Acta 1813(5): 683-694.
61. Sefah K, Bae K-M, Phillips JA , Siemann DW, Su Z, McClellan S, Vieweg J, Tan W (2013) Cell-based selection provides novel molecular probes for cancer stem cells. Int J Cancer 132: 2578-2588.
62. Singh S, Brocker C, Koppaka V , Chen Y, Jackson BC, Matsumoto A, Thompson DC, Vasiliou V (2013) Aldehyde dehydrogenases in cellular responses to oxidative/electrophilic stress. Free Radic Biol Med 56: 89-101.
63. Sládek NE, Kol lander R, Sreerama L, Kiang DT (2002) Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer: A retrospective study. Rational in dividualization of oxazaphosphorine-based cancer chemotherap. Cancer Chemother Pharmacol 49: 309-321.
64. Sun S, Wang Z (2010) ALDH high adenoid cystic carcinoma cells display cancer stem cell properties and are responsible for mediating metastasis. Biochem Biophys Res Commun 396: 843-848.
65. Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, Von Eschenbach AC, Chung LW (1994) Andro gen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 54(10): 2577-2581.
66. Thomas C, Zoubeidi A, Kuruma H, Fazli L, Lamoureux F, Beraldi E, Monia BP, MacLeod AR, Thuroff JW, Gleave ME (2011) Transcription factor Stat5 knockdown enhances androgen receptor degradation and delays castration-resistant prostate cancer progression in vivo. Mol Cancer Ther 10(2): 347-359.
67. Touma SE, Perner S, Rubin MA, Nanus DM, Gudas LJ (2009) Retinoid metabolism and ALDH1A2 (RALDH2) expression are altered in the transgenic adenocarcinoma mouse prostate model. Biochem Pharmacol 78: 1127-1138.
68. Ucar D, Cogle CR, Zucali JR, Ostmark B, Scott EW, Zori R, Gray BA, Moreb JS (2009) Aldehyde dehydrogenase activity as a functional marker for lung cancer. Chem Biol Interact 178: 48-55.
69. Van Den Hoogen C, Van Der Horst G, Cheung H, Buijs JT, Lippitt JM, Guzmán-Raḿrez N, Hamdy FC, Eaton CL, Thalmann GN, Cecchini MG, Pelger RCM, Van Der Pluijm G (2010) High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer. Cancer Res 70: 5163-5173.
70. Van Den Hoogen C, Van Der Horst G, Cheung H, Buijs JT, Pelger RCM, Van Der Pluijm G (2011) The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis. Clin Exp Metastasis 28: 615-625.
71. Vasiliou V, Nebert DW (2005) Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family. Hum Genomics 2(2): 138-143.
72. Vasiliou V Pappa A Petersen DR 2000 Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism Chem Biol Interact 129 1-19.
73. Vasiliou V, Thompson DC, Smith C, Fujita M, Chen Y (2013) Aldehyde dehydrogenases: From eye crystallins to metabolic disease and cancer stem cells. Chem Biol Interact 202(1-3): 2-10.
74. Visvader JE, Lindeman GJ (2008) Cancer stem cells in solid tumours: Accumulating evidence and unresolved questions. Nat Rev Cancer 8(10): 755-768.
75. Wang J, Fang Q, Sun D, Chen J, Zhou X, Lin G, Lu H, Fei J (2001) Genetic modification of hematopoietic progenitor cells for combined resistance to 4HCP, vincristine and daunorubicin. Acta pharmacologica Si nica 22: 949-955.
76. Wang ZA, Mitrofanova A, Bergren SK, Abate-Shen C, Cardiff RD, Califano A, Shen MM (2013) Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity. Nat Cell Biol 15(3): 274-283.
77. Williams H, Powell I (2009) Epidemiology, pathology, and genetics of prostate cancer among African Americans compared with other ethnicities. Methods Mol Biol 472: 439-453.
78. Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, Chu PWK, Lam CT, Poon RTP, Fan ST (2008) Significance of CD90+ cancer stem c ells in human liver cancer. Cancer cell 13: 153-166.
79. Zhang F, Song C, Ma Y, Tang L, Xu Y, Wang H (2011) Effect of fibroblasts on breast cancer cell mammosphere formation and regulation of stem cell-related gene expression. Int J Mol Med 28(3): 365-371.